Trovafloxacin is active against Toxoplasma gondii. 1996

A A Khan, and T Slifer, and F G Araujo, and J S Remington
Department of Immunology and Infectious Diseases. Palo Alto Medical Foundation, California 94301, USA.

Drugs currently used for treatment of toxoplasmosis in pregnant women, congenital infections, immunocompromised patients, and patients with the ocular disease are not always effective or may be dangerous to use; therefore, there is a need for more-effective and less-toxic drugs. Recently, we examined a group of fluoroquinolones for in vitro and in vivo activities against Toxoplasma gondii. Among those examined in vitro (ciprofloxacin, fleroxacin, ofloxacin, temafloxacin, and trovafloxacin), only trovafloxacin significantly inhibited intracellular replication of T. gondii without significant toxicity for host cells. In a murine model of acute toxoplasmosis, 100 or 200 mg of trovafloxacin per kg of body weight per day for 10 days protected 100% of infected mice against death. A dose of 50 mg/kg/day protected 90% of the mice, and a dose of 25 mg/kg/day effected prolongation of time to death. The other fluoroquinolones did not have such in vivo activities. These results indicate that trovafloxacin may be useful for treatment of toxoplasmosis in humans.

UI MeSH Term Description Entries
D009287 Naphthyridines A group of two-ring heterocyclic compounds consisting of a NAPHTHALENES double ring in which two carbon atoms, one per each ring, are replaced with nitrogens.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D014122 Toxoplasma A genus of protozoa parasitic to birds and mammals. T. gondii is one of the most common infectious pathogenic animal parasites of man. Toxoplasma gondii,Toxoplasma gondius,Toxoplasmas,gondius, Toxoplasma
D014124 Toxoplasmosis, Animal Acquired infection of non-human animals by organisms of the genus TOXOPLASMA. Animal Toxoplasmoses,Animal Toxoplasmosis,Toxoplasmoses, Animal
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

A A Khan, and T Slifer, and F G Araujo, and J S Remington
September 2000, The Journal of antimicrobial chemotherapy,
A A Khan, and T Slifer, and F G Araujo, and J S Remington
November 2002, Parasitology research,
A A Khan, and T Slifer, and F G Araujo, and J S Remington
June 1996, Antimicrobial agents and chemotherapy,
A A Khan, and T Slifer, and F G Araujo, and J S Remington
January 1999, SAR and QSAR in environmental research,
A A Khan, and T Slifer, and F G Araujo, and J S Remington
December 1998, Parasite (Paris, France),
A A Khan, and T Slifer, and F G Araujo, and J S Remington
August 1969, Das Deutsche Gesundheitswesen,
A A Khan, and T Slifer, and F G Araujo, and J S Remington
September 1994, Parasitology today (Personal ed.),
A A Khan, and T Slifer, and F G Araujo, and J S Remington
April 1999, Antimicrobial agents and chemotherapy,
A A Khan, and T Slifer, and F G Araujo, and J S Remington
July 2017, Multiple sclerosis and related disorders,
A A Khan, and T Slifer, and F G Araujo, and J S Remington
March 2009, Memorias do Instituto Oswaldo Cruz,
Copied contents to your clipboard!